Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.

Brain : a journal of neurology·2021

Same author

The contribution of behavioral features to caregiver burden in FTLD spectrum disorders.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2021

Same author

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding <sup>18</sup>F-FDG-PET.

Brain communications·2021

Same author

The temporal onset of the core features in dementia with Lewy bodies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2021

Same author

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder.

Journal of Parkinson's disease·2021

Same author

Regional Brain Stiffness Analysis of Dementia with Lewy Bodies.

Journal of magnetic resonance imaging : JMRI·2021

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Dementia with Lewy bodies.

Tanis J Ferman¹, Bradley F Boeve

¹Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL 32224, USA. ferman.tanis@mayo.edu <ferman.tanis@mayo.edu>

Neurologic Clinics

|July 31, 2007

Summary

Dementia with Lewy bodies (DLB) is the second most common dementia. Differentiating DLB from Alzheimer's disease (AD) is crucial for effective treatment strategies and symptom management.

Area of Science:

Neurology
Neuroscience
Pathology

Background:

Dementia with Lewy bodies (DLB) is the second most prevalent neurodegenerative dementia, following Alzheimer's disease (AD).
Advancements in immunostaining techniques enhance the detection of limbic and cortical Lewy bodies, aiding in DLB diagnosis.
Distinguishing DLB from AD is critical for tailoring patient treatment, as certain therapies can exacerbate DLB symptoms while others may offer relief.

Purpose of the Study:

To highlight the clinical features that aid in the early differentiation of dementia with Lewy bodies (DLB) from Alzheimer's disease (AD).
To underscore the importance of accurate diagnosis for optimizing therapeutic interventions in neurodegenerative dementias.

Main Methods:

Review of clinical characteristics differentiating DLB from AD.

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

Derivation of Leptomeninges Explant Cultures from Postmortem Human Brain Donors

Derivation of Leptomeninges Explant Cultures from Postmortem Human Brain Donors

Published on: January 21, 2017

Related Experiment Videos

Last Updated: Jul 13, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

Derivation of Leptomeninges Explant Cultures from Postmortem Human Brain Donors

Derivation of Leptomeninges Explant Cultures from Postmortem Human Brain Donors

Published on: January 21, 2017

Analysis of neurocognitive patterns, psychiatric manifestations, extrapyramidal signs, and sleep disturbances.

Consideration of underlying neuropathological and neurochemical differences, including cholinergic system integrity.

Main Results:

Neurocognitive profiles, psychiatric symptoms, motor signs (extrapyramidal), and sleep disturbances are key differentiators.
Variations in cholinergic deficits and the specific type and location of Lewy body pathology contribute to distinct clinical presentations.
Early identification allows for proactive management of symptoms and avoidance of harmful treatments.

Conclusions:

Clinical features such as cognitive patterns, psychiatric issues, motor symptoms, and sleep problems are vital for early DLB vs. AD diagnosis.
Underlying differences in neuropathology and neurotransmitter systems explain the observed clinical distinctions.
Accurate differentiation of DLB and AD is essential for guiding appropriate and effective patient care and treatment.